Zota healthcare

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Zota HealthCare Ltd is a pharmaceutical company with headquarters in Surat, Gujarat, India. With 23 divisions, it is one of the largest pharmaceutical companies in India. Zota HealthCare has more than 3,300 brands in the Indian market. The company's [1]turn over in 2013 was near INR 1 billion.


Company Timeline[edit]

  • 1995 - Zota Pharmaceuticals founded.
  • 1998 - ATOZ Pharmaceuticals division created.
  • 2002 - Zota Pharmaceuticals completed its first merger with Sayona Pharmaceuticals (Baroda).
  • 2005 - Zota Pharmaceuticals becomes Zota Healthcare Pvt. Ltd.
  • 2006 - Zota HealthCare Pvt. Ltd. inaugurated its corporate offices in Surat.
  • 2009 - Zota HealthCare Pvt. Ltd. allotted a limited number of public shares and became a public Ltd. company, Zota HealthCare Ltd. (ZHCL)
  • 2011 - ZHCL expands business beyond India to South Africa, Nigeria, Ghana, and Kazakhstan.
  • 2012 - ZHCL receives its first ever patent of RT-Fit for liver psoriasis.[2]
  • 2013 - ZHCL nominated for the 2013 Emerging India Award (among 500 Indian companies).
  • 2013 - ZHCL elected from among 800 global pharmaceutical companies by the European Patent Office (EPO) geneva for tele research.
  • 2013 - ZHCL received a second patent of GM-Fit for joint pain management.
  • 2013 - ZHCL applied for a special use patent for the drug, Diclofenac.

[3]

Products[edit]

ZHCL manufactures branded medicines generic medicines and patent products in India.[1] As of October, 2013, ZHCL's main area of focus is on patented products, including RT-Fit and GM-Fit. RT-Fit is approved by PCT (Patent Corporation Treaty) and can be sold by ZHCL in 142 countries. ZHCL intends to apply for 15 more product patents in the Indian market, seven of which will be sent to PCT for approval. [4]

Future plans for Zota HealthCare Ltd[edit]

Zota HealthCare Ltd planned to issue an initial public offering (IPO) in April or May 2014, hoping to raise Rs. 4-5 billion and to invest Rs. 600-700 million in research and development. It also planned to explore business opportunities in the US and Europe market.


References[edit]

  1. ^ a b Zota HealthCare Ltd. "Official Web Site". Retrieved 20 October 2013. 
  2. ^ Express, Pharma. "Zota Healthcare applies for patent in pain management". Retrieved 20 October 2013. 
  3. ^ High Beam Research. "Wipo Publishes Patent of Zota Health Care". US Fed News Service, Including US State News. Retrieved 15 January 2013. 
  4. ^ pharma, biz. "Zota targets overseas markets for its amino acid combo for alcoholism". PharmaBiz. Retrieved 22 October 2013.